Download as PDF, PPTX
Uploaded byHealthegy
Kuldev Singh, MD, PhD
The document provides an overview of the global glaucoma market, highlighting patient demographics, disease categories, and surgical trends. It indicates a significant number of glaucoma patients are unaware of their condition, with many not receiving proper care or being non-compliant. Additionally, it outlines opportunities to improve glaucoma treatment through more effective medications and safer surgical options.
More Related Content
Similar to Kuldev Singh, MD, PhD
Kuldev Singh, MD, PhD
- 1. Spotlight on PressureReduction: Market Overview Kuldev Singh, M.D., M.P.H. Professor of Ophthalmology Director, Glaucoma Service Stanford University
- 2. Glaucoma Patients byRegion 0 20 40 60 80 100 120 140 160 2015 2020 NumberofGlaucomaPatients(millions) Rest of World Latin America India China Other Wealthy Nations Japan Western Europe United States Courtesy of Dave Harmon Market Scope
- 3. Glaucoma by DiseaseCategory Open Angle 42% Closed Angle 15% Secondary 7% Ocular Hypertension 36% 125 Million Courtesy of Dave Harmon Market Scope
- 4. Courtesy of Dr.Cynthia Mattox
- 5. Glaucoma Prevalence byAge Prevent Blindness America Future of Vision Report 2014 Courtesy of Dr. Cynthia Mattox
- 6. Glaucoma: The BigPicture 25-50% aware that they have disease* Those aware are often not under care Those under care are often non compliant Unpredictable natural history of disease Small percentage go blind Lowering IOP reduces but does not eliminate risk *Sommer A, et al. Arch Ophthalmol. 1991;109:1990-95.
- 7. U.S. Ophthalmologists Specialty 41% Courtesy ofDr. Gregory Skuta and AAO Member Services Comprehensive with Specialty 19% Comprehensive 40%
- 8. U.S. Specialty Breakdown Retina/Vitreous 29% Corneaand External Disease 18% Pediatrics and Strabismus 14% Oculoplastics and Orbit 12% Cataract/Anterior Segment 8% Other 3% Neuro 2% Refractive Surgery 1% Uveitis 1% Glaucoma 12% Courtesy of Dr. Gregory Skuta and AAO Member Services
- 9. Global Glaucoma Pharmaceutical MarketRevenues by Category Branded Prostaglandin 28% Generic Prostaglandin 7% Beta Blockers… Carbonic Anhydrase Inhibitors 11% Alpha Agonists 11% Fixed Combo Drugs 37% Other 2% $4.7 Billion in 2015 Courtesy of Dave Harmon Market Scope
- 11. Surgical Trends: 1994-2012 0 20000 40000 60000 80000 100000 120000 140000 160000 180000 200000 Trabec Tube CPC LTP LPI Courtesyof Drs. William Rich, Michael Repka and Gregory Skuta
- 12. 0 50 100 150 200 250 300 2013 2014 2019(Forecast) 64 64 62 44 46 54 20 42 255 USGlaucomaSurgeries(000) Filtration Tube Shunts MIGS U.S. Glaucoma Surgical Procedures Courtesy of Dave Harmon Market Scope
- 13. Spotlight on PressureReduction: Addressing Unmet Needs in Glaucoma Care More effective first line and adjunctive medications Glaucoma operation safer than trabeculectomy Novel drug delivery to improve compliance
- 14. SPOTLIGHT ON PRESSUREREDUCTION Company Presentations